Clinical Trials on Autoimmune Polyendocrine Syndrome Type II
Total 8756 results
-
National Taiwan University HospitalRecruitingAutoimmune Polyendocrine Syndrome Type IITaiwan
-
Medical University of ViennaUnknown
-
The Eye Center and The Eye Foundation for Research...CompletedAutoimmune Polyglandular Syndrome Type I | Autoimmune Keratitis
-
Hospital for Special Surgery, New YorkNot yet recruitingChronic Pain | Complex Regional Pain Syndrome | Causalgia | Complex Regional Pain Syndrome Type I | Complex Regional Pain Syndrome Type IIUnited States
-
La Jolla Pharmaceutical CompanyTerminatedHepatorenal Syndrome Type I and Type IIUnited States
-
Johns Hopkins UniversityTerminatedGlossopharyngeal Neuralgia | Trigeminal Neuralgia (Burchiel Type I) | Trigeminal Neuralgia (Burchiel Type II) | Trigeminal Neuropathic Pain | Trigeminal Deafferentation Pain | Complex Regional Pain Syndrome (Types I and II, Involving the Upper Extremity) | Upper Extremity Pain Due to Deafferentation... and other conditionsUnited States
-
National Institute of Nursing Research (NINR)National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver... and other collaboratorsTerminatedComplex Regional Pain Syndrome Type I | Complex Regional Pain Syndrome Type IIUnited States
-
Hospices Civils de LyonUnknownNeurological Syndromes With GAD-Ab | Organ-specific Autoimmune Diseases
-
Michael Camilleri, MDNGM Biopharmaceuticals, IncCompletedIrritable Bowel Syndrome With Diarrhea | Bile Acid Malabsorption | Chronic Diarrhea | Functional Diarrhea | Bile Acid Diarrhea | Bile Acid Malabsorption Syndrome Type IIUnited States
-
Mayo ClinicCompletedCongenital Myasthenic SyndromeUnited States
-
Institut de Myologie, FranceAssistance Publique - Hôpitaux de ParisCompletedCongenital Myasthenic Syndrome
-
argenxRecruitingCongenital Myasthenic SyndromeSpain, France, United States, Canada
-
Catalyst Pharmaceuticals, Inc.CompletedMyasthenic Syndromes, CongenitalUnited States
-
Medtronic Diabetes R&D DenmarkUnknownDiabetes Mellitus Type II | Diabetes Mellitus Type IDenmark
-
Northwestern UniversityUniversity of Illinois at ChicagoCompletedDiabetes Mellitus Type II | Diabetes Mellitus Type IUnited States
-
University of Colorado, DenverApproved for marketingLambert Eaton Myasthenic SyndromeUnited States
-
Jacobus PharmaceuticalCompletedLambert-Eaton Myasthenic Syndrome | Eaton-Lambert Myasthenic SyndromeUnited States
-
Vern C. Juel, M.D.No longer available
-
Ricardo MaselliCatalyst Pharmaceuticals, Inc.No longer availableCongenital Myasthenic SyndromeUnited States
-
Japan Tobacco Inc.CompletedType II HyperlipidaemiaNetherlands
-
Catalyst Pharmaceuticals, Inc.CompletedA Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)Lambert Eaton Myasthenic SyndromeUnited States, Spain, Serbia, Russian Federation, Hungary, France, Germany, Poland
-
David P. Richman, MDJacobus PharmaceuticalNo longer available
-
University of ZurichBalgrist University HospitalRecruitingComplex Regional Pain Syndrome I (CRPS I) | Complex Regional Pain Syndromes | Osteoarthritis Hand | Complex Regional Pain Syndrome Type II | Complex Regional Pain Syndrome Type I of the Upper Limb | Complex Regional Pain Syndrome I of Upper Limb | Complex Regional Pain Syndrome II of Upper Limb | Peripheral Nerve Injury Upper Limb and other conditionsSwitzerland
-
Institut de Myologie, FranceAssociation Française contre les Myopathies (AFM), ParisCompletedMyasthenia Gravis | Lambert-Eaton Myasthenic Syndrome | Congenital Myasthenic Syndrome | Autoimmune Myasthenia GravisFrance
-
Bellus Health IncCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome XCanada
-
REGENXBIO Inc.Active, not recruitingMucopolysaccharidosis Type II (MPS II)United States, Brazil
-
Lahey ClinicApproved for marketingLambert-Eaton Myasthenic Syndrome | Congenital Myasthenic SyndromeUnited States
-
Orpha LabsCompletedLeukocyte Adhesion Deficiency, Type II
-
David Lacomis, MDJacobus PharmaceuticalNo longer availableLambert-Eaton Myasthenic Syndrome
-
Catalyst Pharmaceuticals, Inc.CompletedLambert-Eaton Myasthenic SyndromeUnited States
-
The Cleveland ClinicNo longer availableLambert-Eaton Myasthenic SyndromeUnited States
-
Hadassah Medical OrganizationUnknown
-
HealthInsightCenter for Technology and Aging; VoxivaUnknownType II Diabetes MellitusUnited States
-
Microbio Co LtdCompleted
-
KeyBioscience AGEli Lilly and Company; Profil Institut für Stoffwechselforschung GmbH; Nordic...TerminatedType II Diabetes MellitusGermany
-
Hospices Civils de LyonActive, not recruitingAutoimmune Encephalitis | Paraneoplastic Neurological SyndromeFrance
-
pico-tesla Magnetic Therapies, LLCCompletedType II Diabetes MellitusUnited States
-
Catalyst Pharmaceuticals, Inc.No longer availableLambert-Eaton Myasthenic Syndrome | Congenital Myasthenic Syndrome | Nystagmus, AcquiredUnited States
-
Louis H. Weimer, MDNo longer availableLambert Eaton Myasthenic Syndrome (LEMS)United States
-
University Hospital, BordeauxTEVA laboratoriesCompletedMultiple Sclerosis | Brain MRI | Clinically Isolated Demyelinating Syndromes | Cognitive DeficienciesFrance
-
Meshalkin Research Institute of Pathology of CirculationUnknownAorta-iliac Segment Lesion (C,D Type by TASC II)Russian Federation
-
FDA Office of Orphan Products DevelopmentDuke UniversityCompletedLambert-Eaton Myasthenic Syndrome
-
Mansoura UniversityCompletedMyasthenia Gravis | Guillain-Barre SyndromeEgypt
-
University of PretoriaNestlè Nutrition Institute Africa; South African Sugar AssociationCompletedDiabetes Mellitus, Type II [Non-insulin Dependent Type] [NIDDM Type] UncontrolledSouth Africa
-
Oslo University HospitalUniversity of OsloCompletedShort Bowel Syndrome | Intestinal Pseudo-Obstruction | Bacterial Overgrowth | Malabsorption Syndrome Autoimmune EnteropathyNorway
-
University of TorontoAgriculture and Agri-Food CanadaCompletedObesity | Metabolic Syndrome | Type II Diabetes MellitusCanada
-
Arizona State UniversityCatholic Charities Phoenix; Phoenix International Refugee Committee; Refugee... and other collaboratorsCompletedFemale Genital Mutilation Type I Status | Female Genital Mutilation Type II Status | Female Genital Mutilation Type III StatusUnited States
-
Ohio State UniversityOsato Research InstituteCompletedWound | Negative Pressure Therapy | Open Wound | Type II Obese Diabetic | Type II Non-Obese DiabeticUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany